The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically
Day: April 11, 2019
A fungus, an antibiotic, a parasite, and a cure
Researchers have turned a fungus into a disease-curing factory through modern genetic engineering and patience. The natural antibiotic is a
Research reveals how the most common ALS mutation dooms cells
St. Jude Children’s Research Hospital scientists have cracked the mystery surrounding the most common genetic cause of amyotrophic lateral sclerosis
Biochemical switches identified that could be triggered to treat muscle, brain disorders
St. Jude Children’s Research Hospital scientists have found that the enzymes ULK1 and ULK2 play a key role in breaking
Anti-inflammatory medicine can have a beneficial effect on depression
Up to fifteen per cent of the Danish population will develop symptoms of depression at some point in their lives. The
The protein p38gamma identified as a new therapeutic target in liver cancer
An enzyme involved in cell stress responses could become a new pharmacological target in the treatment of liver cancer, a
Active lifestyles may help nerves to heal after spinal injuries
Leading an active lifestyle may increase the likelihood of damaged nerves regenerating after a spinal cord injury. The early-stage findings,
Remaining healthy with a weak immune system
White blood cells, antibodies, and other components, including organs and lymph nodes, make up the body’s immune system. Many disorders
Specialist enzymes make E. coli antibiotic resistant at low pH
Scientists long puzzled over why bacteria contain so many “redundant” enzymes. Why make several molecules that do the same job,
Protein pileup affects social behaviors through altered brain signaling
Scientists at the RIKEN Center for Brain Science (CBS) have discovered that when a normal cellular cleanup process is disrupted,
